Spinal Modulation Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 116

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $175M

Spinal Modulation General Information

Description

Developer of spinal cord stimulation technology intended to focus on the treatment of chronic pain. The company's spinal cord stimulation technology is the developer of a targeted spinal cord stimulation (SCS) device that targets the dorsal root ganglion (DRG), delivering electrical pulses that interrupt pain signals as they travel from the DRG to the brain, enabling patients to get faster relief from chronic pain.

Contact Information

Website
www.spinalmodulation.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1135 O'Brien
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Therapeutic Devices
Acquirer
St. Jude Medical
Corporate Office
  • 1135 O'Brien
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spinal Modulation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-May-2015 $175M Completed Generating Revenue
5. Later Stage VC (Series E) 10-Jun-2013 Completed Generating Revenue
4. Later Stage VC (Series D) 07-Jun-2011 Completed Generating Revenue
3. Later Stage VC (Series C) 04-Nov-2009 Completed Startup
2. Early Stage VC (Series B) 31-Mar-2008 $15.2M $22.5M Completed Startup
1. Early Stage VC (Series A) 24-Jan-2006 $7.27M $7.27M Completed Startup
To view Spinal Modulation’s complete valuation and funding history, request access »

Spinal Modulation Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 10,133,328 $0.000100 8% $1.5 $1.5 1x $1.16 16.74%
Series A 8,881,370 $0.000100 8% $0.82 $0.82 1x $0.82 11.32%
To view Spinal Modulation’s complete cap table history, request access »

Spinal Modulation Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of spinal cord stimulation technology intended to focus on the treatment of chronic pain. The company's spinal
Therapeutic Devices
Menlo Park, CA
116 As of 2015

Austin, TX
 

Norwalk, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spinal Modulation Competitors (34)

One of Spinal Modulation’s 34 competitors is MicroTransponder, a Venture Capital-Backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MicroTransponder Venture Capital-Backed Austin, TX
BioWave Venture Capital-Backed Norwalk, CT
Saluda Medical Private Equity-Backed Artarmon, Australia
Mainstay Medical Venture Capital-Backed San Diego, CA
Aleva Neurotherapeutics Private Equity-Backed Lausanne, Switzerland
You’re viewing 5 of 34 competitors. Get the full list »

Spinal Modulation Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spinal Modulation Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Barshop Ventures Family Office Minority
De Novo Ventures Venture Capital Minority
Draper Fisher Jurvetson Management Venture Capital Minority
InCube Ventures Corporate Venture Capital Minority
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Spinal Modulation FAQs

  • When was Spinal Modulation founded?

    Spinal Modulation was founded in 2004.

  • Where is Spinal Modulation headquartered?

    Spinal Modulation is headquartered in Menlo Park, CA.

  • What is the size of Spinal Modulation?

    Spinal Modulation has 116 total employees.

  • What industry is Spinal Modulation in?

    Spinal Modulation’s primary industry is Therapeutic Devices.

  • Is Spinal Modulation a private or public company?

    Spinal Modulation is a Private company.

  • What is the current valuation of Spinal Modulation?

    The current valuation of Spinal Modulation is .

  • What is Spinal Modulation’s current revenue?

    The current revenue for Spinal Modulation is .

  • How much funding has Spinal Modulation raised over time?

    Spinal Modulation has raised $124M.

  • Who are Spinal Modulation’s investors?

    Barshop Ventures, De Novo Ventures, Draper Fisher Jurvetson Management, InCube Ventures, and Johnson & Johnson Innovation - JJDC are 5 of 13 investors who have invested in Spinal Modulation.

  • Who are Spinal Modulation’s competitors?

    MicroTransponder, BioWave, Saluda Medical, Mainstay Medical, and Aleva Neurotherapeutics are some of the 34 competitors of Spinal Modulation.

  • When was Spinal Modulation acquired?

    Spinal Modulation was acquired on 01-May-2015.

  • Who acquired Spinal Modulation?

    Spinal Modulation was acquired by St. Jude Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »